ESR1 and breast cancer: Given the reported hypersensitivity of the mutant ESR1 A908G mutant receptor to estrogen, it was of interest to determine whether hormonal risk factors in the CBCS might be associated with breast cancer characterized by the presence or absence of the ESR1 A908G mutation.